REPS. DINGELL, STUPAK RESPOND TO FDA'S RANBAXY ANNOUNCEMENT
September 16, 2008
September 16, 2008
WASHINGTON, Sept. 16 -- The House Energy & Commerce Committee issued the following news release:
Democratic leaders of the House Committee on Energy and Commerce reacted to the Food and Drug Administration's (FDA) announcement today that it would partially restrict imports manufactured by Ranbaxy, Inc. at two of the company's plants in India. In July, Reps. John D. Dingell (D-MI), Chairman of the Committee, and Bart Stupak (D-MI), Chairman of its Subcommittee on Oversight and . . .
Democratic leaders of the House Committee on Energy and Commerce reacted to the Food and Drug Administration's (FDA) announcement today that it would partially restrict imports manufactured by Ranbaxy, Inc. at two of the company's plants in India. In July, Reps. John D. Dingell (D-MI), Chairman of the Committee, and Bart Stupak (D-MI), Chairman of its Subcommittee on Oversight and . . .